Mortality rates from coronavirus disease 2019 (COVID-19) remain higher than those from influenza. Based on real-world data, remdesivir initiation was associated with significant mortality reduction among patients hospitalized for COVID-19 not requiring supplemental oxygen on admission across variants of concern periods.
All Keywords
【저자키워드】 COVID-19, Mortality, Hospitalization, Remdesivir, comparative effectiveness research,
【저자키워드】 COVID-19, Mortality, Hospitalization, Remdesivir, comparative effectiveness research,